Lower riskDrug recall · FDA · Published October 23, 2023
Major Pharmaceuticals Phenytoin Oral Suspension Recall: Failed Content Uniformity
Major Pharmaceuticals recalls Phenytoin Oral Suspension due to failed content uniformity specifications. This may affect medication dosing accuracy. Contact for remedy details.
“Major Pharmaceuticals Phenytoin Oral Suspension Recall: Failed Content Uniformity.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33032-major-pharmaceuticals-phenytoin-oral-suspension-recall-failed-content-uniformity. Based on FDA recall #D-0153-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0153-2024%22&limit=1).
The FDA announced on Oct. 23, 2023, that Major Pharmaceuticals and Rugby Laboratories are voluntarily recalling Phenytoin Oral Suspension due to failed content uniformity specifications. The Class I recall affects 3,718 saleable units distributed nationwide.
How to tell if you have it
Brand: Major Pharmaceuticals
Product: Phenytoin Oral Suspension, USP, 100 mg/4 mL
Packaging: 4 mL unit dose cups (NDC 0904-7079-24), 50 per case (NDC 0904-7079-57)
Lot codes: C00099, C00115 (Exp. 07/31/2024); C00079 (Exp. 12/31/2023)
The hazard
The product failed content uniformity specifications, according to the FDA. The recall is classified as Class I.
Context
GovInfoNow's records show the brand has 14 other recalls on record since May 31, 2023. Other recent recalls of similar products include Major Chlorpromazine 50mg Tablets Recall (Sept. 12, 2025), Major Pharmaceuticals Sulfamethoxazole-Trimethoprim Recall (Sept. 2, 2025), and Major Pharmaceuticals Carvedilol Tablets Recall (Aug. 20, 2025).
How to tell if you have this one
Check for the product name 'Phenytoin Oral Suspension, USP, 100 mg/4 mL' in 4 mL unit dose cups. Look for lot numbers C00099, C00115 (expiring 07/31/2024) or C00079 (expiring 12/31/2023).
Brand
Major Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the lot number and expiration date on the packaging to confirm if it's in the recalled batch.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0153-2024 (October 23, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0153-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.